Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts
- PMID: 20385637
- PMCID: PMC2884182
- DOI: 10.1542/peds.2009-2317
Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts
Abstract
Objective: The objective of this study was to assess the risk of suicide attempts and suicides after initiation of antidepressant medication use by children and adolescents, for individual agents.
Methods: We conducted a 9-year cohort study by using population-wide data from British Columbia. We identified new users of antidepressants who were 10 to 18 years of age with a recorded diagnosis of depression. Study outcomes were hospitalization attributable to intentional self-harm and suicide death.
Results: Of 20,906 children who initiated antidepressant therapy, 16,774 (80%) had no previous antidepressant use. During the first year of use, we observed 266 attempted and 3 completed suicides, which yielded an event rate of 27.04 suicidal acts per 1000 person-years (95% confidence interval [CI]: 23.9-30.5 suicidal acts per 1000 person-years). There were no meaningful differences in the rate ratios (RRs) comparing fluoxetine with citalopram (RR: 0.97 [95% CI: 0.54-1.76]), fluvoxamine (RR: 1.05 [95% CI: 0.46-2.43]), paroxetine (RR: 0.80 [95% CI: 0.47-1.37]), and sertraline (RR: 1.02 [95% CI: 0.56-1.84]). Tricyclic agents showed risks similar to those of selective serotonin reuptake inhibitors (RR: 0.92 [95% CI: 0.43-2.00]).
Conclusion: Our finding of equal event rates among antidepressant agents supports the decision of the Food and Drug Administration to include all antidepressants in the black box warning regarding potentially increased suicidality risk for children and adolescents beginning use of antidepressants.
Figures
Comment in
-
Expose, heed, and coordinate care: priorities for mental health promotion and suicide prevention.Pediatrics. 2010 May;125(5):1064-5. doi: 10.1542/peds.2010-0610. Epub 2010 Apr 12. Pediatrics. 2010. PMID: 20385638 No abstract available.
Similar articles
-
Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.Arch Gen Psychiatry. 2010 May;67(5):497-506. doi: 10.1001/archgenpsychiatry.2010.39. Arch Gen Psychiatry. 2010. PMID: 20439831 Free PMC article.
-
[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].Presse Med. 2006 Oct;35(10 Pt 2):1507-15. doi: 10.1016/s0755-4982(06)74843-6. Presse Med. 2006. PMID: 17028514 Review. French.
-
Antidepressants and the risk of suicidal behaviors.JAMA. 2004 Jul 21;292(3):338-43. doi: 10.1001/jama.292.3.338. JAMA. 2004. PMID: 15265848
-
[Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].Encephale. 2005 May-Jun;31(3):309-16. doi: 10.1016/s0013-7006(05)82395-4. Encephale. 2005. PMID: 16142045 French.
-
Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.Curr Med Chem. 2012;19(12):1846-63. doi: 10.2174/092986712800099749. Curr Med Chem. 2012. PMID: 22414078 Review.
Cited by
-
Paroxetine-Overview of the Molecular Mechanisms of Action.Int J Mol Sci. 2021 Feb 7;22(4):1662. doi: 10.3390/ijms22041662. Int J Mol Sci. 2021. PMID: 33562229 Free PMC article. Review.
-
Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.Cochrane Database Syst Rev. 2014 Sep 19;2014(9):CD006997. doi: 10.1002/14651858.CD006997.pub2. Cochrane Database Syst Rev. 2014. PMID: 25238582 Free PMC article.
-
Automated data-adaptive analytics for electronic healthcare data to study causal treatment effects.Clin Epidemiol. 2018 Jul 6;10:771-788. doi: 10.2147/CLEP.S166545. eCollection 2018. Clin Epidemiol. 2018. PMID: 30013400 Free PMC article. Review.
-
Conducting Privacy-Preserving Multivariable Propensity Score Analysis When Patient Covariate Information Is Stored in Separate Locations.Am J Epidemiol. 2017 Mar 15;185(6):501-510. doi: 10.1093/aje/kww155. Am J Epidemiol. 2017. PMID: 28399565 Free PMC article.
-
Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.CNS Drugs. 2014 Jan;28(1):79-88. doi: 10.1007/s40263-013-0120-8. CNS Drugs. 2014. PMID: 24146116 Free PMC article.
References
-
- Food and Drug Administration Summary minutes of the September 13–14, 2004 Center for Drug Evaluation and Research Pharmachopharmacologic Drugs Advisory Committee and the FDA Pediatric Advisory Committee. [February 1, 2005]. Available at: www.fda.gov/ohrms/dockets/ac/04/minutes/2004-4065M1_Final.htm.
-
- Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with anti-depressant drugs. Arch Gen Psychiatry. 2006;63(3):332–339. - PubMed
-
- Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry. 2006;63(12):1358–1367. - PubMed
-
- Olfson M, Marcus SC, Shaffer D. Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study. Arch Gen Psychiatry. 2006;63(8):865–872. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
